How the speed of single-use equipment adoption by Contract manufacturing organizations is outpacing the speed of biopharma innovators for small and mid-scale bioprocessing.
With the government aiming to introduce TMR on non-scheduled drugs as a measure to reduce the cost of drugs, there has been a significant increase in the number of people who is opposing TMR and is supporting the implementation of the one molecule...
Eli Lilly and Co said it plans to make its COVID-19 antibody drug commercially available to U.S. states as well as hospitals and other healthcare providers from August...
Strides Pharma Science on Wednesday said it has received approval from the US health regulator to market a generic immunosuppressant medication in the American market. The Bengaluru-based company said its step-down wholly-owned subsidiary,...
The European Commission said it had signed a joint procurement contract with Spanish pharmaceutical firm HIPRA for the supply of its protein COVID-19 vaccine, which will be available if approved by the European Medicines Agency (EMA)...
Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said...
Cadila Pharmaceuticals has launched the generic versions of Sitagliptin in India under the brand names Jankey & Sitenali to address type 2 diabetes...
Importance of the recently launched schemes by the government to strengthen Micro, Small, and Medium Enterprises in the pharma sector
Domestic drug companies are readying plans to manufacture anti-virals and other medicines which may be effective for monkeypox. At present, there is scant data on treatment and companies are awaiting guidelines from international health agencies...
Dr Reddy's Laboratories said it has entered into a pact with US-based Slayback Pharma to acquire rights of a medication to relieve redness of the eyes. The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights...
, CDSCO.jpg)
